0001209191-19-002148.txt : 20190104 0001209191-19-002148.hdr.sgml : 20190104 20190104173325 ACCESSION NUMBER: 0001209191-19-002148 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190102 FILED AS OF DATE: 20190104 DATE AS OF CHANGE: 20190104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldberg Jeff Marc CENTRAL INDEX KEY: 0001703061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 19511267 MAIL ADDRESS: STREET 1: C/O AKCEA THERAPEUTICS STREET 2: 55 CAMBRIDGE PARKWAY, STE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-207-0202 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF RD STREET 2: 9TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-02 0 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001703061 Goldberg Jeff Marc C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210 0 1 0 0 Chief Operating Officer Common Stock 2019-01-01 4 J 0 493 21.5135 A 2880 D Stock Option (right to buy) 30.73 2019-01-02 4 A 0 150000 0.00 A 2029-01-01 Common Stock 150000 150000 D Although not required, the Reporting Person is voluntarily reporting the acquisition of 493 shares on January 1, 2019 pursuant to the Issuer's Employee Stock Purchase Plan. The shares vest as follows: 1/4th of the shares vest one year after January 2, 2019; 1/48th of the shares vest monthly thereafter over the next three years. /s/ Paula Soteropoulos, Attorney-in-Fact 2019-01-04